Detalles de la búsqueda
1.
Efficacy and safety of donepezil in patients with dementia with Lewy bodies: results from a 12-week multicentre, randomised, double-blind, and placebo-controlled phase IV study.
Psychogeriatrics
; 24(3): 542-554, 2024 May.
Artículo
Inglés
| MEDLINE | ID: mdl-38439118
2.
A phase I pharmacokinetic study of lenvatinib in Chinese patients with unresectable hepatocellular carcinoma.
Future Oncol
; 18(22): 2413-2424, 2022 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-35674480
3.
Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures.
Epilepsia
; 61(1): 125-137, 2020 01.
Artículo
Inglés
| MEDLINE | ID: mdl-31912493
4.
Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study.
J Neurol Neurosurg Psychiatry
; 90(4): 451-457, 2019 04.
Artículo
Inglés
| MEDLINE | ID: mdl-30636701
5.
Disease state changes and safety of long-term donepezil hydrochloride administration in patients with Alzheimer's disease: Japan-Great Outcome of Long-term trial with Donepezil (J-GOLD).
Psychogeriatrics
; 18(5): 402-411, 2018 Sep.
Artículo
Inglés
| MEDLINE | ID: mdl-29993162
6.
Disease state changes and safety of long-term donepezil hydrochloride administration in patients with Alzheimer's disease: interim results from the long-term, large-scale J-GOLD study in Japan.
Psychogeriatrics
; 16(2): 107-15, 2016 Mar.
Artículo
Inglés
| MEDLINE | ID: mdl-26114729
7.
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort.
Clin Cancer Res
; 30(7): 1264-1272, 2024 Apr 01.
Artículo
Inglés
| MEDLINE | ID: mdl-38295160
8.
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort.
Cancer Res Commun
; 4(1): 226-235, 2024 01 29.
Artículo
Inglés
| MEDLINE | ID: mdl-38181055
9.
Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (aged 4 to <12 years) with inadequately controlled focal-onset seizures: Japanese subgroup analysis.
Seizure
; 110: 109-116, 2023 Aug.
Artículo
Inglés
| MEDLINE | ID: mdl-37336055
10.
Liposomal eribulin for advanced adenoid cystic carcinoma, gastric cancer, esophageal cancer, and small cell lung cancer.
Cancer Med
; 12(2): 1269-1278, 2023 01.
Artículo
Inglés
| MEDLINE | ID: mdl-35864593
11.
Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort.
Clin Cancer Res
; 29(8): 1460-1467, 2023 04 14.
Artículo
Inglés
| MEDLINE | ID: mdl-36730323
12.
Phase Ib/II Study of a Liposomal Formulation of Eribulin (E7389-LF) plus Nivolumab in Patients with Advanced Solid Tumors: Results from Phase Ib.
Cancer Res Commun
; 3(7): 1189-1199, 2023 07.
Artículo
Inglés
| MEDLINE | ID: mdl-37435605
13.
Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind study.
Ann Gen Psychiatry
; 11(1): 15, 2012 Jun 25.
Artículo
Inglés
| MEDLINE | ID: mdl-22731653
14.
Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors.
Clin Cancer Res
; 28(9): 1783-1791, 2022 05 02.
Artículo
Inglés
| MEDLINE | ID: mdl-35180771
15.
Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort.
Eur J Cancer
; 168: 108-118, 2022 06.
Artículo
Inglés
| MEDLINE | ID: mdl-35500404
16.
Efficacy and safety of lemborexant in adults with insomnia: comparing Japanese and non-Japanese subgroups from the global, phase 3, randomized, double-blind, placebo-controlled SUNRISE 2 study.
J Clin Sleep Med
; 17(5): 1067-1074, 2021 05 01.
Artículo
Inglés
| MEDLINE | ID: mdl-33576735
17.
Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
Dement Geriatr Cogn Disord
; 27(3): 232-9, 2009.
Artículo
Inglés
| MEDLINE | ID: mdl-19246907
18.
Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial.
J Alzheimers Dis
; 52(1): 345-57, 2016 03 11.
Artículo
Inglés
| MEDLINE | ID: mdl-26967222
19.
[A double-blind comparative study to evaluate the efficacy and safety of NerBloc® (rimabotulinumtoxinB) administered in a single dose to patients with cervical dystonia].
Brain Nerve
; 65(2): 203-11, 2013 Feb.
Artículo
Japonés
| MEDLINE | ID: mdl-23399677
Resultados
1 -
19
de 19
1
Próxima >
>>